Beaird Harris Wealth Management, LLC Ionis Pharmaceuticals Inc Transaction History

Beaird Harris Wealth Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 24, 2023	SELL	$33.58 - $41.2 $2,081 - $2,554	-62 Reduced 1.22%	5,000 $178,000
Q4 2022 Feb 14, 2023	BUY	$37.12 - $46.52 $2,301 - $2,884	62 Added 1.24%	5,062 $191,000
Q3 2022 Nov 02, 2022	BUY	$36.54 - $48.66 $182,700 - $243,299	5,000 New	5,000 $221,000
Q2 2022 Aug 12, 2022	SELL	$31.71 - $43.0 $158,550 - $215,000	-5,000 Closed	0 $0
Q4 2021 May 17, 2022	BUY	$25.61 - $35.1 $128,050 - $175,500	5,000 New	5,000 $152,000

403

136M

862K

582K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.35B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Beaird Harris Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Beaird Harris Wealth Management, LLC with notifications on news.